You have entered the address of a Kleresca® site outside your country. Please be aware that information on the site may not apply to your country.
The Kleresca® technology offers non-destructive, non-systemic, and painless treatments that use fluorescent light (FLE) energy to stimulate the skin’s natural balance, reducing pimples, redness, and flushing2-13.
The treatment is based on the interaction between a specially designed gel and the Kleresca® Light. Chromophores in the gel convert the blue light from the Kleresca® Light into fluorescent light energy that penetrates the skin and activates its healing responses13.
In this context, biophotonic refers to the interaction between the light and your skin9,10. Kleresca®’s biophotonic treatment represents a completely new way of treating rosacea.
Photobiomodulation is a mechanism where light stimulates the cells in the body leading to different beneficial clinical effects and stimulation of its own repair mechanisms9,10. It has already been used for the treatment of Acne and for Skin Rejuvenation with very positive results3-6.
The chromophores in the gel convert the blue light from the lamp into fluorescent light energy that covers the spectra from green over yellow and orange to red at once2,3,12.
The fluorescence generated (dynamic, ultrafast pulsing light) penetrates the different layers of the skin, triggering documented healing responses and activating its healing mechanisms2,3,12.
Kleresca® Rosacea Treatment is an effective, non-destructive, and painless treatment that targets unpleasant stinging and burning sensations9-13.
The treatment promotes the development of blood vessels in the treated skin. Contrary to what you might think, this actually reduces erythema and blushing. New blood vessels can disperse the blood accumulated and at the same time nourish the cells with oxygen and nutrients, helping them in their activities.
The recommended protocol depends on the rosacea type and the severity of its symptoms. We recommend that you assess the severity and type of rosacea, as well as quality of the patients’ skin before deciding on the best protocol for them.
The total number of treatments generally varies between 4 to 6, once or twice per week, depending on the rosacea type and its severity.
Scientific publications have shown the effectiveness and safety on the treatment in erythematotelangiectatic and papulopustular rosacea, as well as showing improvements in phymatous rosacea. This includes an overall improvement of the skin quality and rosacea signs and symptoms in all the treated patients1-3.
Kleresca® Rosacea Treatment can be combined with other rosacea treatments, but this is always subject to the judgement of the treating clinician or practitioner1,13.
PDT (Photodynamic Therapy) is a form of phototherapy that involves light and a topical drug that gets activated with the light. The drug will get absorbed by the patient’s skin and then be activated with the light to induce a destruction of skin cells for the treatment of some skin conditions.
FLE, on the other hand, is non-destructive, non-systemic and painless alternative to drugs. The gel is not being absorbed, it is only used to convert the blue light of the Kleresca® Light into Fluorescent Light Energy (FLE). Only the light will penetrate the skin and activate its own repair mechanisms.
Currently, four products are available on the Kleresca® Technology platform: Kleresca® Rosacea Treatment, Kleresca® Acne Treatment, Kleresca® Skin Rejuvenation and Kleresca® Pre-Post Treatment. Each indication features a specifically formulated gel. This is then utilized with specific pre-programmed settings in the Kleresca® Light.
The Kleresca® Rosacea Treatment uses a multi-LED lamp (Light Emitting Diode) as its energy source. Harmful UV light is not emitted by the system. With different publications showing high safety and efficacy, Kleresca® Rosacea Treatment is a well-tolerated treatment with no serious side effects reported.
The patented Kleresca® Light, with pre-programmed wavelength settings specific to each indication, has been developed and tested to efficiently cause the chromophores to photoconvert blue light, thereby creating fluorescent light energy (FLE)13.
The gel stays on the surface of the skin and its purpose is to convert the light emitted by the lamp into fluorescent light energy (FLE). FLE then provides beneficial effects by way of modulation of the biological processes in the multiple layers of the skin.
Yes. Kleresca® Treatments do not induce photosensitivity and patients do not need to avoid sun exposure during or after the treatments. However, people should protect themselves against the harmful UV light of the sun with sunscreen.
Kleresca® FLE treatments are generally gentle and comfortable. Being non-invasive, there is no destruction or removal of the skin’s natural barriers. The gel used during the treatment is not absorbed by the skin, so no substance in it can induce a photosensitive reaction.
The system is easy to use and complementary training is also offered as part of a certification program for clinic staff. Kleresca® Academy offers complementary information about the technology and the skin as well. The purpose of the Kleresca® Academy is to broaden your clinic’s staff knowledge as well as to share this knowledge among professionals.
Kleresca® Rosacea Treatment is described as a pleasant and comfortable experience with a high degree of safety and efficacy. The technology has been on the market since 2014 with no serious adverse events reported. Side effects – seen in some patients – are all non-permanent and may include redness and hyperpigmentation (bronzing of an area of the skin). Side effects impact patients differently depending on their skin type. These possible side effects should be discussed with your patient before starting the treatment in order to manage expectations.